Robert F Lindgren, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 13011 S 104th Ave Ste 203, Palos Park, IL 60464 Phone: 708-923-7900 Fax: 708-923-7915 |
News Archive
The MetLife Foundation Journalists in Aging Fellows Program - responsible for nearly 200 news stories by 48 alumni to date - will continue for a fourth year thanks to a grant renewal from the MetLife Foundation.
Are wind farms harmful to humans? Some believe so, others refute this; this controversial topic makes emotions run high. To give the debate more objectivity, an international team of experts dealt with the fundamentals of hearing in the lower limit range of the audible frequency range (i.e. infrasound), but also in the upper limit range (i.e. ultrasound).
Emerging Healthcare Solutions, Inc.: Last week, the US Food and Drug Administration gave their highly-anticipated approval for the first clinical trial using human embryonic stem cells (hESCs), which are the type of cells that can develop into all tissues of the body. Geron Corporation of Menlo Park, California, received the green light from the US FDA to use cells derived from hESCs to treat people with acute spinal cord injuries. Ten people will receive injections into the injury site of hESC-derived oligodendrocyte progenitor cells, which stimulate the growth of new and severed nerves and recoat damaged nerves with myelin. The hope is that the injections will help people recover function lost through injury, as seen in rodent studies in 2005.
Canadian Blood Services has reviewed the KPMG report entitled "Independent Review of New Brunswick Blood Options", commissioned by the Government of New Brunswick and the New Brunswick Medical Society.
In a major breakthrough, researchers at Massachusetts General Hospital (MGH) have discovered how amyloid beta-the neurotoxin believed to be at the root of Alzheimer's disease (AD)-forms in axons and related structures that connect neurons in the brain, where it causes the most damage.
› Verified 2 days ago